TrueTear Intranasal Tear Neurostimulator— 510(k) K193589

Substantially Equivalent

Allergan

FDA 510(k) clearance K193589 for TrueTear Intranasal Tear Neurostimulator, Substantially Equivalent on 2020-08-31. Applicant: Allergan.

Clearance details

Applicant: Allergan
Product code: Code QBR
Advisory panel: Ophthalmic
Date received: 2019-12-23
Decision date: 2020-08-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.